A NEW HPLC METHOD FOR THE QUANTIFICATION OF PANTOPRAZOLE IN PHARMACEUTICALS

Similar documents
International Journal of Pharmacy and Pharmaceutical Sciences Vol 2, Issue 1, 2010

Stability-indicating HPLC determination of tolterodine tartrate in pharmaceutical dosage form

7. Stability indicating analytical method development and validation of Ramipril and Amlodipine in capsule dosage form by HPLC.

RP-HPLC METHOD FOR THE ESTIMATION OF PANTOPRAZOLE SODIUM

CHAPTER 19 PARACETAMOL + IBUPROFEN

Impact factor: 3.958/ICV: 4.10 ISSN:

Received: ; Accepted:

Volume 6, Issue 2, January February 2011; Article-015

SIMULTANEOUS RP HPLC DETERMINATION OF CAMYLOFIN DIHYDROCHLORIDE AND PARACETAMOL IN PHARMACEUTICAL PREPARATIONS.

STABILITY INDICATING RP HPLC METHOD FOR ANALYSIS OF DORZOLAMIDE HCl IN THE BULK DRUG AND IT S PHARMACEUTICAL DOSAGE FORM

Reverse Phase High Performance Liquid Chromatography method for determination of Lercanidipine hydrochloride in bulk and tablet dosage form

DETERMINATION OF DRUG RELEASE DURING DISSOLUTION OF NICORANDIL IN TABLET DOSAGE FORM BY USING REVERSE PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY

RP-HPLC Estimation of Trospium Chloride in Tablet Dosage Forms

VALIDATION STUDY OF THE HPLC ASSAY OF SOME ANTIAMOEBIC AGENTS

STABILITY INDICATING METHOD OF RELATED IMPURITIES IN VENLAFAXINE HYDROCHLORIDE SUSTAINED RELEASE TABLETS

Validated spectrophotometric determination of Fenofibrate in formulation

Validated RP-HPLC Method for Estimation of Cefprozil in Tablet Dosage Form

Journal of Chemical and Pharmaceutical Research, 2012, 4(6): Research Article. Estimation of zaleplon by a new RP-HPLC method

Simultaneous HPLC Determination of Methocarbamol, Paracetamol and Diclofenac Sodium

Journal of Pharmaceutical and Biomedical Analysis Letters. Analysis Letters

INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND LIFE SCIENCES

CHAPTER INTRODUCTION OF DOSAGE FORM AND LITERATURE REVIEW

Available online Research Article

Department of Quality Assurance, Luqman College of Pharmacy, GULBARGA (K.S.) INDIA ABSTRACT

MICROTITRIMETRIC DETERMINATION OF A DRUG CONTENT OF PHARMACEUTICALS CONTAINING OLANZAPINE IN NON-AQUEOUS MEDIUM

Development and validation a RP-HPLC method: Application for the quantitative determination of quetiapine fumarate from marketed bulk tablets

ANALYTICAL METHOD PROCEDURES

J Pharm Sci Bioscientific Res (4): ISSN NO

Chapter-4 EXPERIMENTAL WORK BY RP-HPLC

Pelagia Research Library

SIMPLE AND SENSITIVE VALIDATED REVERSE PHASE HPLC-UV METHOD FOR THE DETERMINATION OF LYMECYCLINE IN PHARMACEUTICAL DOSAGE FORMS

A Simple, Novel Validated Stability Indicating RP-HPLC method for estimation of Duloxetine HCl in Capsule Pharmaceutical Formulation

SIMULTANEOUS ESTIMATION OF CILOSTAZOL AND ASPIRIN IN SYNTHETIC MIXTURE USING HPTLC METHOD

Spectroscopic Method For Estimation of Atorvastatin Calcium in Tablet Dosage Form

Dissolution study and method validation of alprazolam by high performance liquid chromatography method in pharmaceutical dosage form

A RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF PARA- PHENYLENEDIAMINE IN PURE FORM AND IN MARKETED PRODUCTS

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD TO DETERMINE CINITAPRIDE HYDROGEN TARTARATE IN BULK AND PHARMACEUTICAL FORMULATION

Development and Validation of RP-HPLC Method for the Estimation of Repaglinide in Bulk Drug and Pharmaceutical Formulation

Development and Validation of Stability Indicating RP-HPLC Method for the Determination of Anagrelide HCl in Pharmaceutical Formulation

INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY AND BIO SCIENCES

Development and validation of RP-LC method for lisinopril dihydrate in bulk and its pharmaceutical formulations

Method Development and Validation Of Prasugrel Tablets By RP- HPLC

International Journal of Pharma and Bio Sciences V1(1)2010. HPLC method for analysis of Lercanidipine Hydrochloride in Tablets

Method Development and Validation for the Estimation of Darunavir in Rat Plasma by RP-HPLC

Validated spectrophotometric determination of pantoprazole sodium in pharmaceuticals using ferric chloride and two chelating agents

Received: ; Accepted:

Simultaneous Estimation of Residual Solvents (Isopropyl Alcohol and Dichloromethane) in Dosage Form by GC-HS-FID

Research Article Available online at

Research Article. Identification and characterization of unknown impurity in zolmitriptan tablets by a sensitive HPLC method

RP-HPLC Method Development and Validation of Dapagliflozin in Bulk and Tablet formulation

Stability indicating RP-HPLC method for determination of azilsartan medoxomil in bulk and its dosage form

High-Performance Liquid Chromatographic Method for the Analysis of Fluconazole in Pharmaceutical Preparations

Chapter 4: Verification of compendial methods

Stability Indicating RP-HPLC Method for Determination of Valsartan in Pure and Pharmaceutical Formulation

DEVELOPMENT AND VALIDATION OF A HPLC METHOD FOR IN-VIVO STUDY OF DICLOFENAC POTASSIUM

Analytical method development and method validation for the estimation of pantoprazole in tablet dosage form by RP-HPLC

Journal of Drug Delivery and Therapeutics

Validated First Order Derivative Spectroscopic Method for the determination of Stavudine in Bulk and Pharmaceutical Dosage Forms

Validation of Stability-Indicating RP-HPLC Method for the Assay of Ibrutinib in Pharmaceutical Dosage form

Development and Validation of Sensitive RP-HPLC Method for the Estimation of Glibenclamide in Pure and Tablet Dosage Forms

Zero And First Order Derivative Spectrophotometric Methods For Determination Of Dronedarone In Pharmaceutical Formulation

Research Article METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF ELBASVIR AND GRAZOPREVIR BY RP-HPLC

Ketorolac tromethamine (KT)[1] is

Int. J. Pharm. Sci. Rev. Res., 30(2), January February 2015; Article No. 09, Pages: 63-68

Radhakrishnan K. et al. / International Journal of Pharmacy & Therapeutics, 3(1), 2012, e- ISSN Print ISSN

Liquid Chromatography and Spectroscopic Method for Estimation of Sulphadoxine in Marketed Formulation

Analytical Method Development and Validation of Lafutidine in Tablet dosage form by RP-HPLC

SIMULTANEOUS ESTIMATION OF MEFENAMIC ACID AND PARACETAMOL IN SUSPENSION FORM BY USING UPLC

METHOD DEVELOPMENT AND VALIDATION OF RALTEGRAVIR POTASSIUM AND RILPIVIRINE HCL BY HPLC AND HPTLC METHODS

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Department of Pharmaceutical Chemistry, Poona College of Pharmacy, Bharati Vidyapeeth University, Erandwane, Pune , India

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR QUANTITATIVE ANALYSIS OF GABAPENTIN IN PURE AND PHARMACEUTICAL FORMULATIONS

Development and Validation of RP-HPLC Method for Acid Resistance and Assay of Esomeprazole Magnesium in Esomeprazole Magnesium Pellets

Simultaneous estimation of ramipril and valsartan by RP-HPLC method in combined. dosage form

Development and Validation of a Stability-Indicating RP-HPLC Method for Analysis of Racecadotril in Pharmaceutical Dosage Forms

DEVELOPMENT AND VALIDATION OF ULTRA PERFORMANCE LIQUID CHROMATOGRAPHIC METHOD FOR ASSAY OF OMEPRAZOLE BLEND

K Basavaiah * & U Chandrashekar

KEYWORDS: Acetaminophen, Doxylamine succinate, Dextromethorphan hydrobromide.

CHAPTER - 3 ANALYTICAL PROFILE. 3.1 Estimation of Drug in Pharmaceutical Formulation Estimation of Drugs

TEMPLATE FOR AN EXAMPLE STANDARD TEST METHOD

International Journal of Current Trends in Pharmaceutical Research. International Journal of Current Trends in Pharmaceutical Research

Asian Journal of Research in Chemistry and Pharmaceutical Sciences Journal home page:

Novus International Journal of Analytical Innovations 2012, Vol. 1, No. 3

CHAPTER - IV. Acharya Nagarjuna University, Guntur 105

Development and Validation of a HPLC Method for Determination of Anastrozole in Tablet Dosage Form

2.1 2,3 Dichloro Benzoyl Cyanide (2,3 DCBC) and survey of. manufactured commonly for the bulk drug industry, few references were

Development and Validation of Stability-Indicating RP-HPLC Method for Estimation of Atovaquone

RP-HPLC Method for Simultaneous Estimation of Atenolol, Hydrochlorothiazide and Losarton in Tablet Dosage form

DEVELOPMENT AND VALIDATION OF A RP-HPLC METHOD FOR DETERMINATION OF LOPINAVIR IN BULK AND PHARMACEUTICAL DOSAGE FORM

Isocraticc Reverse Phase HPLC Method-Determination and Validation of Cilostazol

Determination of Fexofenadine Hydrochloride in Pharmaceutical Dosage Form By Reverse Phase High Performance Liquid Chromatography Method

Research Article. Figure 1. Chemical structure of doxofylline. Indonesian J. Pharm. Vol. 24 No. 1 : ISSN-p :

Development and Validation of UV Spectrophotometric Estimation of Diclofenac Sodium Bulk and Tablet Dosage form using Area under Curve Method

Journal of Chemical and Pharmaceutical Research

DEVELOPMENT AND VALIDATION OF HPLC METHOD FOR THE ESTIMATION OF NICERGOLINE IN MARKETED FORMULATIONS

4.1 MATERIALS 4.2 EQUIPMENTS

B. Anupama et al. IRJP 2 (1)

VALIDATION OF A UPLC METHOD FOR A BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE TOPICAL SOLUTION

HPLC Method Development and Validation for the estimation of Esomeprazole in Bulk and Pharmaceutical Dosage Form

Simultaneous UV Spectrophotometric Method for the Estimation of Cefuroxime Axetil and Probenecid from Solid Dosage Forms

Transcription:

Int. J. Chem. Sci.: 6(2), 2008, 579-586 A NEW HPLC METHOD FOR THE QUANTIFICATION OF PANTOPRAZOLE IN PHARMACEUTICALS K. BASAVAIAH, U. R. ANIL KUMAR and K. THARAPA Department of Chemistry, University of Mysore, Manasagangotri, MYSORE - 570 006 (K. S.) INDIA ABSTRACT A new analytical method is developed and appropriately validated by means of a high performance liquid chromatography (HPLC) in reverse phase to quantify pantoprazole in pharmaceutical preparations. The HPLC determination was performed on a reversed phase column (Inertsil ODS 5µm; 150 x 4.6 mm i.d) using a mobile phase (0.6 ml min -1 ) with UV-detection at 289 nm. A rectilinear relationship between mean peak area and concentration of PNT was observed in the range 25-200 µg ml -1 with a detection limit of 6.0 µg ml -1 and a quantitation limit of 20.0 µg ml -1. Intra-day and interday precision, and accuracy of the methods have been established according to the current ICH guidelines. The results were statistically compared with those of the reference method by applying Student s t-test and F-test. Accuracy, evaluated by means of the spike recovery method was in the range 97.7-102.2%, with precision (RSD) better than 2%. Key words: Pantoprazole, Quantification, HPLC, Pharmaceuticals INTRODUCTION Pantoprazole sodium sesquihydrate (PNT) is chemically known as sodium 5- (difluoromethoxy)-2-[(3,4-dimethoxy-2-p-methyl]sulfinyl]-1h-benzimidazole sesqui hydrate 1. Pantoprazole inhibits H + K + AT Pase pump function; thereby, healing the acid related conditions. PNT is chemically more stable than omeprazole and lansoprazole in neutral to mildly acidic conditions, but under strongly acidic medium, active species is formed. PNT like omeprazole and lansoprazole also has a role in the eradication of Helicobacter Pylori 2. The literature survey reveals that only few methods are available for the determination of PNT in dosage forms in HPLC. Author for correspondence; E-mail: basavaiahk@yahoo.co.in

580 K. Basavaiah et al.: A New HPLC Method. Structure of pantoprazole Ding et al 3. have reported chiral HPLC method for the determination of PNT. In their method PNT was determined on Chiral column (5 µm, 150 mm x 4.6 mm) with methanol : water (35 : 65, v/v) as mobile phase. The flow rate was 0.6 ml min -1. Enantiomeric separation of PNT was also reported by Ding et al 4. They have used hexaneisopropanol-acetic acid mixture (95 : 5 : 0.1, v/v) as the mobile phase at a flow rate of 2.0 ml min -1 at 25 C. Xue-Hui et al. 5 have reported determination of PNT in capsule by HPLC on a C18 column with mobile phase of MeCN-phosphate buffer (35 : 65), and detection at 288 nm. The reported linearity is in the range of 20-60 µg ml -1. The other methods available includes HPTLC 6, UV spectrophotometry 7, chemometry 8 and visible spectrometry 9,10. This paper deals with the development and validation of a sensitive method for the assay of PNT in pharmaceuticals, based on HPLC technique. The separation and determination were done on a reversed phase Inertsil ODS column with UV-detection at 289 nm. The method was demonstrated to be both; accurate and precise, which qualify it to be adopted for routine use in pharmaceutical quality control laboratories. Apparatus EXPERIMENTAL The chromatographic system consisted of an Agilent 1100 series chromatograph equipped with an in built solvent degasser, quaternary pump, photo diode array detector with variable injector and auto sampler, and a reversed phase 5 µm Inertsil ODS column (150 x 4.6 mm, i.d.). Reagents and standards All chemicals used were of analytical reagent grade and HPLC grade acetonitrile (Merck. Ltd, Mumbai) was used. Distilled water filtered through 0.45 µm filter (Millipore) was used to prepare solutions.

Int. J. Chem. Sci.: 6(2), 2008 581 The mobile phase A was prepared by dissolving 6.8 g of KH 2 PO 4 and 1 g of 1- hexane sulphonic acid in 1000 ml distilled water and it was adjusted to ph 7.3 with 1M NaOH. Acetonitrile was used as mobile phase B. The mobile phase used was prepared by mixing mobile phase A and mobile phase B in the ratio, 70 : 30. The mobile phase was used as a diluent for the sample preparations. Pharmaceutical grade PNT, certified to be 99.8 % pure was procured from Cipla India Ltd, Mumbai, India, and was used as received. A stock standard containing 500 µg ml -1 PNT solution was prepared by dissolving accurately weighed 25 mg of pure drug in diluent and diluting to 50 ml in a calibrated flask with diluent. Procedures Chromatographic conditions The separation was achieved at temperature of 35 C on the column using the mobile phase at a flow rate of 0.6 ml min -1. The detector wavelength was set at 289 nm with a sensitivity of 0.2 a.u.f.s. Calibration graph Working standard solutions equivalent to 25 to 200 µg ml -1 PNT were prepared by appropriate dilution of stock standard solution (500 µg ml -1 ) with the diluent solution. Ten µl aliquot of each solution was injected automatically on to the column in duplicate and the chromatograms were recorded. Calibration graph was prepared by plotting the mean peak area versus concentration of PNT. The concentration of the unknown was read from the calibration graph or computed from the regression equation derived from the mean peak area-concentration data. Assay in dosage forms A quantity of tablet powder equivalent 50 mg of PNT was accurately weighed into a 100 ml calibrated flask, 60 ml of diluent solution added and contents were shaken for 20 min., Then the volume was diluted to the mark and mixed well. A small portion of the extract (say 10 ml) was withdrawn and filtered through 0.2 µm filter to ensure the absence

582 K. Basavaiah et al.: A New HPLC Method. of particulate matter. The filtered solution was appropriately diluted with the diluent solution for analysis as described already. Method development RESULTS AND DISCUSSION A solution of PNT was injected in duplicate on to the column and was monitored by UV-detection at 289 nm. Mobile phase consisting of mobile phase A : mobile phase B (70 : 30) was used after several preliminary experiments. At a flow rate of 0.6 ml min -1, the retention time was 7.355 min (Fig. 1). Under the described experimental conditions, the peak was well-defined and free from tailing. PNT was determined by measuring the peak area. A plot of mean peak area against concentration (Fig. 2) gave a linear relationship (r = 0.99987, n = 5) over the concentration range 25-200 µg ml -1. Using the regression analysis, the linear equation, Y = 31.3774 + 21.0704 X was obtained, where Y is the mean peak area and X is the concentration in µg ml -1. The limits of detection and quantification calculated as per ICH guidelines 11 were 6.0 and 20.0 µg ml -1, respectively. Fig. 1: Typical chromatogram

Int. J. Chem. Sci.: 6(2), 2008 583 Method validation Accuracy and precision Fig. 2: Linearity curve To determine the accuracy and intra-day precision, pure PNT solutions at three different concentrations were analyzed in seven replicates. The percent relative error, which is an index of accuracy, is < 1.0% and it is indicates good accuracy. The relative standard deviation (< 1%) at the 95% confidence level can be considered to be satisfactory. Table 1. Accuracy and intra-day precision PNT taken PNT found* Range (µg ml 1 ) RE (%) RSD* (%) RSD** (%) 50 49.50 0.70 1.00 0.73 0.21 100 99.82 0.95 0.18 0.23 0.32 150 149.2 1.30 0.53 0.26 0.15 RE. relative error; RSD. Relative standard deviation; *Mean value of seven determinations;* Based on peak area; ** Based on retention time

584 K. Basavaiah et al.: A New HPLC Method. The inter-day precision was established by performing analyses over a period of five days on solutions prepared afresh each day. The peak-area based and retention-timebased RSD values were < 2.0 % and < 1 %, respectively. Application The results obtained are presented in Table 2 and compared well with label claim. The results were also compared statistically with those obtained by a reference method 3 by applying Student s t-test for accuracy and F-test for precision. At the 95% confidence level, the calculated t- and F-values did not exceed the tabulated values (t = 2.77 and F = 6.39) suggesting that the proposed methods are as accurate and precise as the reference method. Table 2. Determination of pantoprazole in formulations and statistical compared with the reference method Formulation Brand name * Nominal amount (mg) Reference method % Found* ± SD Proposed method t-value F-value PAN a 20 101.2 ± 0.62 100.8 ± 1.29 0.66 4.33 PANTOCIP b 40 97.3 ± 1.05 98.2 ± 0.95 1.42 1.22 PANTOP c 40 101.5 ± 0.85 100.9 ± 1.2 0.92 1.99 *Mean value of seven determinations **Marketed by: a. Alkem Ltd.; b. Cipla Ltd.; c. Aristo Ltd. Tabulated t-value at 95% confidence level is 2.77 Tabulated F-value at 95% confidence level is 6.39. The accuracy and validity of the proposed methods were further ascertained by performing recovery experiments. Preanalysed tablet powder was spiked with pure PNT at three different levels and the total was found by the proposed methods. Each determination was repeated three times. The recovery of pure drug added was quantitative (Table 3) and it revealed that coformulated substances such as talc, starch, gelatin, gum acacia, calcium carbonate, calcium gluconate, calcium dihydrogen orthophosphate, sodium alginate and magnesium stearate did not interfere in the determination.

Int. J. Chem. Sci.: 6(2), 2008 585 Table 3. Recovery experiments Formulation studied PAN-20 PANTOP-40 PNT in formulation, *Mean value of three determinations PNT added, Total found Pure PNT recovered* (%) 25.2 25 50.15 99.8 25.2 75 101.85 102.2 25.2 125 150.58 100.3 25.2 25 50.08 99.5 25.2 75 98.48 97.7 25.2 125 151.70 101.2 CONCLUSIONS The proposed method is simple, rapid and convenient and it is characterized by shorter retention time and a wide linear dynamic range of concentration, over which, it is applicable. There was no interference from matrix sources. REFERENCES 1. The Merck Index, 12 th Edn, Merck and Co. Inc, White House Stations, NJ, (1997) p. 1205. 2. Current Index of Medical Specialities (CIMS), CMP Medica India Pvt. Ltd., Bangalore, India, July-October, (2005) p. 76. 3. G. Ding, A. Tang, J. Wang, R. Cong and J. Bao, Sepu, 24, 46 (2006); (2006) ACS on Scifinder; CAN 144, 199119; AN (2006), 141860. 4. G. Ding, R. Cong and J. Wang, Sepu, 22, 241 (2004); (2006) ACS on Scifinder; CAN 141, 59853; AN (2004), 563455. 5. H. Xue-Hui and P. Fu-Sheng, Zhongguo Yiyao Gongye Zazhi, 31, 502 (2000); ACS on Scifinder; CAN 134, 91243; AN (2001), 5(2063). 6. D. Agbaba, D. Novovic, K. Karljikovic-Rajic and V. Marinkovic, J. Planar Chromatogr. Mod. TLC, 17, 169 (2004).

586 K. Basavaiah et al.: A New HPLC Method. 7. K. Karljikovic-Rajic, D. Novovic, V. Marinkovic and D. Agbaba, J. Pharm. Biomed. Anal., 32, 1019 (2003). 8. M. Wahbi Abdel-Aziz, O. Abdel-Razak, A. A. Gazy, H. Mahgoub and M. S. Moneeb, J. Pharm. Biomed. Anal., 30, 1133 (2002). 9. F. Salama, N. El-Abasawy, S. A. A. Razeq, M. F. Ismail and M. M. Fouad, Bull. Fac. Pharm (Cairo University), 41, 185 (2003). 10. A. A. M. Moustafa, J. Pharm. Biomed. Anal., 22, 45 (2000). 11. Validation of Analytical Procedures; Methodology, International Conference on Harmonization (ICH), Text and Methodology Q2(R 1), Complementary Guideline on Methodology, 6 November 1996, incorporated in November, 2005, London. Accepted : 12.03.2008